Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
Open Access
- 26 January 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3), 1203
- https://doi.org/10.3390/ijms22031203
Abstract
A high-throughput drug screen identifies potentially promising therapeutics for clinical trials. However, limitations that persist in current disease modeling with limited physiological relevancy of human patients skew drug responses, hamper translation of clinical efficacy, and contribute to high clinical attritions. The emergence of induced pluripotent stem cell (iPSC) technology revolutionizes the paradigm of drug discovery. In particular, iPSC-based three-dimensional (3D) tissue engineering that appears as a promising vehicle of in vitro disease modeling provides more sophisticated tissue architectures and micro-environmental cues than a traditional two-dimensional (2D) culture. Here we discuss 3D based organoids/spheroids that construct the advanced modeling with evolved structural complexity, which propels drug discovery by exhibiting more human specific and diverse pathologies that are not perceived in 2D or animal models. We will then focus on various central nerve system (CNS) disease modeling using human iPSCs, leading to uncovering disease pathogenesis that guides the development of therapeutic strategies. Finally, we will address new opportunities of iPSC-assisted drug discovery with multi-disciplinary approaches from bioengineering to Omics technology. Despite technological challenges, iPSC-derived cytoarchitectures through interactions of diverse cell types mimic patients’ CNS and serve as a platform for therapeutic development and personalized precision medicine.This publication has 219 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Human ESC/iPSC-based ‘omics’ and bioinformatics for translational researchDrug Discovery Today: Disease Models, 2013
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent stateGenes & Development, 2011
- Modelling familial dysautonomia in human induced pluripotent stem cellsPhilosophical Transactions B, 2011
- Huntington's DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in SynucleinopathiesOnline Journal of Public Health Informatics, 2010
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004